Sort
34,240 grants matching “atherosclerosis”
A Neurobehavioral Family Study of Schizophrenia
$592,758University Of Pennsylvania · R01 · FY2002 · MH
Effect of cell-based therapies on functional, hemodynamic, and histologic outcomes in a porcine model of peripheral arterial disease
$592,674Iraklis Ilias Pipinos · University Of Nebraska Medical Center · R01 · FY2022 · AG
Clonal Hematopoiesis of Indeterminate Potential in Chronic Kidney Disease Patients
$592,640Tanika Nicole Kelly · University Of Illinois At Chicago · R01 · FY2024 · DK
Molecular Regulation of Atherosclerosis Regression
$592,634Edward A Fisher · New York University School Of Medicine · R01 · FY2008 · HL
LncRNA SNHG12, vascular senescence, and atherosclerosis
$592,620Mark W Feinberg · Brigham And Women'S Hospital · R01 · FY2022 · HL
In vivo functions of adhesion and signaling molecules
$592,566Rodger Paul McEver · Oklahoma Medical Research Foundation · P01 · FY2014 · HL
Project 2 - Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs
$592,550Sanjay Srivastava · University Of Louisville · P42 · FY2025 · ES
Sphingolipid mediators in atherogenesis
$592,514Timothy Tun Hla · University Of Connecticut Sch Of Med/Dnt · P01 · FY2013 · HL
The PREDICTS risk score for increased atherosclerosis and disease activity in SLE
$592,470Maureen A McMahon · University Of California Los Angeles · R01 · FY2015 · AR
Neighborhoods and Cardiovascular Risk in a Multiethnic Cohort
$592,445Lynda D Lisabeth · University Of Michigan At Ann Arbor · R01 · FY2013 · HL
The Oral Microbiome in Type 1 Diabetes and Sub-Clinical Cardiovascular Disease
$592,439Amy Christine Alman · University Of South Florida · R01 · FY2019 · DE
Comprehensive functional genomic analysis of the multi-disease associated CDKN2A/B locus
$592,428Gang Li · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG
Determinants of Myogenic, Fibroblastic, and Neuronal Membrane Phenomena
$592,426Alan F Horwitz · University Of Virginia · R01 · FY2013 · GM
Mediterranean diet, Metabolites, and cardiovascular Disease
$592,401Frank B Hu · Harvard School Of Public Health · R01 · FY2017 · HL
PPAR-gamma and REVERBs Attenuate Atherosclerosis by Modulating Tregs and Th17 Ce
$592,380Ronald M. Evans · University Of California, San Diego · P01 · FY2015 · HL
MESA
$592,352Karol Watson · · N01 · FY2015 · HL
miR-181b, endothelial cells, and vascular inflammation
$592,253Mark W Feinberg · Brigham And Women'S Hospital · R01 · FY2021 · HL
Heme toxicity and vaso-occlusion in sickle cell disease
$592,192Gregory M Vercellotti · University Of Minnesota · R01 · FY2015 · HL
In Vivo Photoactoustic Sensing of Lipid Laden Plaque
$591,880Ji-Xin Cheng · Purdue University · R01 · FY2015 · HL
Preventing vascular calcification in kidney disease
$591,857Peter S Rowe · University Of Kansas Medical Center · R01 · FY2025 · HL
Biophysics of HDL Dysfunction
$591,775Kirkwood A Pritchard · Medical College Of Wisconsin · R01 · FY2015 · HL
Trial of Antioxidant Therapy of CVD in Women
$591,750Brigham And Women'S Hospital · R01 · FY2003 · HL
CD37 as a Regulator of Platelet Patho(Physiological) Responses
$591,682Tessa Barrett · New York University School Of Medicine · R01 · FY2025 · HL
CD37 as a Regulator of Platelet Patho(Physiological) Responses
$591,682Tessa Barrett · New York University School Of Medicine · R01 · FY2023 · HL
Role for prelamin A in premature and physiological aging
$591,558Susan D. Michaelis · Johns Hopkins University · R01 · FY2023 · AG